U.S., Aug. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07789717) titled 'Pharmacopuncture for Aromatase Inhibitor Induced Arthralgia (AIA)' on Aug. 05.
Brief Summary: This is a pragmatic pilot trial designed to compare and evaluate the efficacy, safety, and cost-effectiveness of pharmacopuncture treatment versus a control group in aromatase inhibitor-induced arthralgia patients with breast cancer.
Study Start Date: Jan. 05
Study Type: INTERVENTIONAL
Condition:
Breast Cancer
Aromatase Inhibitor
Aromatase Inhibitor Induced Arthralgia
Intervention:
PROCEDURE: pharmacopuncture therapy
It is a modified form of acupuncture treatment in which a small amount of herbal medicine is inserted into acupoints. ...